Clinical Trial Update: INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions [Phase 3]

View source ↗

Summary

Phase 3 trial comparing inhaled salbutamol to placebo for acute IgE-mediated abdominal pain from allergic food reactions; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ige-mediated Abdominal Pain

Drugs mentioned

• Salbutamol (inhaled) (salbutamol)

Snippet

Sponsor: Philippe Bégin | Conditions: IgE-mediated Abdominal Pain | Phase 3 | Status: TERMINATED